Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration. (Q39288785)
Jump to navigation
Jump to search
scientific article published on 21 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration. |
scientific article published on 21 December 2013 |
Statements
Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration (English)
Manuel M Hermann
Philipp S Muether
Dzenita Smailhodzic
Peter Lichtner
Carel B Hoyng
Bernd Kirchhof
Anneke I den Hollander